Epicranial Application of Stimulation Electrodes for Epilepsy

EASEE®: For therapy-resistant focal epilepsies

1 of 3
Epilepsy patients is therapy resistant

EASEE® offers a well-reversible option when resection is not feasible.

  • High effectiveness
  • Favorable safety profile
  • Stimulation is customizable and imperceptible
  • The skull remains intact
  • Not visible from the outside
  1. Technology
  2. Effects
  3. Studies
How does EASEE® work?

Technological Innovation

innovative design
EASEE® Technology
The innovative electrode arrangement allows deep and focused brain stimulation - without touching it.
  • Effective and flexible
  • Subcutaneous placement
  • Precise and individual
  • Ultra Low Power Microelectronics
  • Two different, complementary stimulation patterns

Effects of EASEE®

Clinical Efficacy

Clinical Efficacy
Patients benefit from a reduction in seizures
  • 53% responder rate
  • Excellent tolerability
  • Stimulation imperceptible
  • System is not visible from the outside
EASEE® Effects

Pre-clinical and clinical studies


53,13% Responder Rate

The EASEE® System has been tested for safety and efficacy in adult patients with focal epilepsy in several European study centers. For two of the clinical studies that began in 2019 and 2020, we expect further long-term results soon.

EASEE® Studies
Registration for our Newsletter
News about epilepsy for healthcare professionals directly to inbox
Thank you for your interest in our newsletter
We sent you an email to verify your address. Please open the email and click the link to receive our newsletter
We look forward to keeping you informed at regular intervals
Yes, I'm interested in EASEE® and would like to receive information about it via email. I can withdraw my consent at any time with effect for the future.
We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience with it. For more information about how we use your data, please see our privacy policy.